Although newer atypical antipsychotic drugs have become the standard treatment of schizophrenia and schizoaffective disorders in youth, older antipsychotics may be as effective and safer than widely used second-generation antipsychotic drugs in children and adolescents with such disorders, according to a study funded by the National Institute of Mental Health (Sikich L et al. Am J Psychiatry. 10.1176/appi.ajp.2008.08050756 [published online ahead of print on September 15, 2008]).
Children and Antipsychotics. JAMA. 2008;300(16):1876. doi:10.1001/jama.300.16.1876-b
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: